NCT Number: NCT00191932
Switching to Duloxetine From Other Antidepressants
A multicentre, randomised, open label study of out-patients with major depression who have failed to respond adequately to antidepressant treatment for their current episode of depression. The study compares outcomes associated with two methods of switching from current antidepressant to duloxetine
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Caen, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male and female outpatients of at least 18 years of age, who meet criteria for Major Depressive Disorder (MDD)
- Currently non- or only partially-responsive to an SSRI antidepressant after at least 5 weeks of treatment
Exclusion criteria
include:
- Current primary Axis I disorder other than MDD
- Previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorders
- Patients judged to be at serious suicidal risk.
- Serious medical illness
Treatment and study plan
Primary outcomes
-
To test the hypothesis that the efficacy associated with direct switch from SSRI to duloxetine is non-inferior to start-taper switch
Secondary outcomes
-
To compare the efficacy, health outcomes, safety and tolerability associated with the above two switching methods, as measured by HAMD17, CGI-S, PGI-I, SF-36, spontaneously reported adverse events , vital signs and other measures.
Sponsors and collaborators
Lead sponsor
Eli Lilly and Company
Industry
Registry information
Official study title
Switching to Duloxetine From Other Antidepressants: A Regional Multicentre Trial Comparing Two Switching Techniques
Important dates
- Study start
- 2004
- Study completion
- 2006
- First posted
- Sep 19, 2005
- Registry last updated
- Jul 25, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Trial of Mirtazapine for Depression in IBD
NCT06309472
Behavior, Behavioral Symptoms
London, United Kingdom
View Trial DetailsA Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
NCT06254612
Depressive Disorder, Depressive Disorder, Major
Phoenix, Arizona, United States
View Trial DetailsExamination of Glutamate and mGluR5 in Psychiatric Disorders
NCT02727972
Behavior, Behavioral Symptoms
New Haven, Connecticut, United States
View Trial DetailsImpact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression
NCT04448327
Depressive Disorder, Depressive Disorder, Major
Charlestown, Massachusetts, United States
View Trial Details